Despite targeted therapies and immunotherapies have revolutionized the treatment of
cancer patients, only a limited number of patients have long-term responses. Moreover, due …

It is strongly established that metabolic reprogramming mediates the initiation, progression,
and metastasis of a variety of cancers. However, there is no common biomarker identified to …

Abstract Background NUPR1, or p8, is a small chromatin protein that plays a central role in
the resistance to treatment and progression of cancer. Nevertheless, the molecular …

Human telomeres are linked to genetic instability and a higher risk of developing cancer.
Therefore, to improve the dismal prognosis of pancreatic cancer patients, a thorough …

Background The molecular diversity exhibited by diffuse large B-cell lymphoma (DLBCL) is
a significant obstacle facing current precision therapies. However, scoring using the …

The aetiology of keloid formation remains unclear, and existing treatment modalities have
not definitively established a successful approach. Therefore, it is necessary to identify …

Introduction Natural killer (NK) cells play an irreplaceable and important role as a subtype of
innate immune cells in the contemporary setting of antitumor immunity. Methods We chose a …

Objective: The purpose of the study was to investigate the role of exosome and lipid
metabolism-related genes (EALMRGs) mRNA levels in the diagnosis and prognosis of …

Background The specific differentiation potential, unlimited proliferation, and self-renewal
capacity of cancer stem cells (CSCs) are closely related to the occurrence, recurrence, and …

Bladder urothelial carcinoma (BLCA) is a common malignant tumor of the human urinary
system, and a large proportion of BLCA patients have a poor prognosis. Therefore, there is …